News and Comments

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...


Recent Postings


Archive


Tags

Illumina (ILMN) Genentech Intercept (ICPT) GUARDIAN HEALTH Array Pharmaceuticals (ARRY) Agenus (AGEN Intrexon (XON) Sangamo (SGMO) Trastuzumab-DM1 IDERA (IDRA) Merck (MRK) ISIS (ISIS) Human Longevity (HLI) Alnylam (ALNY) Ridaforolimus VANDA (VNDA) KERYX (KERX) Dynavax (DVAX) Intermune (ITMN) Onyx (ONXX) Jazz Pharmaceuticals (JAZZ) Human Genome Sciences (HGSI) Valeant Pharmaceuticals International (VRX) Aimmune Therapeutics (AIMT) Ionis (IONS) Multiple Myeloma Vitae Pharmaceuticals (VTAE) ACADIA (ACAD) Bristol-Myers Squibb (BMY) Prosensa (RNA) ADVENTRIX (ANX) AERIE PHARMACEUTICALS Tysabri Gilead (GILD) REGULUS (RGLS) Inovio (INO) Ariad (ARIA) Galena (GALE) Xoma (XOMA) Elan (ELN) Auspex (ASPX) C4 Therapeutics ABBVIE (ABBV) GlaxoSmithKline (GSK) Biocryst (BCRX) NANTKWEST (NK) Sanofi (SNA) Regeneron (REGN) Seattle Genetics (SGEN) Vertex (VRTX) SUNESIS PHARMACEUTICALS (SNSS) Roche (ROCHE) Biogen Idec (BIIB) Prolor Biotech (PBTH) Sarepta (SRPT) ImmunoGen (IMGN) Idenix (IDIX) KITE (KITE) ARCA (ABIO) Theravance (THRX) Anadys (ANDS) TOKAI (TKAOI) Rapamune JUNO (JUNO) Revlimid (lenolidamide) OSI (OSIP) SERES THERAPEUTICS (MCRB) Amgen (AMGN) CompuGen (CGEN) BIOMARIN (BMRN) NEKTAR (NKTR)) Anacor (ANAC) Alder Biopharmaceuticals (ALDR) Zerenex Pluristem (PSTI) Agenus (AGEN) Ziofpharm (ZIOP) Dendreon (DNDN) Benlysta (belimumab) Mirati Therapeutics (MRTX) Theravance Bio Pharma (TBPH) Incyte (INCY) Sequenom (SQNM) Abbott Laboratories (ABT) Herceptin Cytokinetics (CYTK) Micromet (MITI) Telaprevir Exelixis (EXEL) HALOZYME (HALO) ZALTRAP™ Sanofi-Aventis (SAN) Roche (RHHBY) Sanofi (SNY) Endometrial Cancer SYNTA (SNTA) Velcade (bortezomib) galapagos (GLPG)